CA1325171C - Spectroscopic method and apparatus for measuring sugar concentrations - Google Patents

Spectroscopic method and apparatus for measuring sugar concentrations

Info

Publication number
CA1325171C
CA1325171C CA 583123 CA583123A CA1325171C CA 1325171 C CA1325171 C CA 1325171C CA 583123 CA583123 CA 583123 CA 583123 A CA583123 A CA 583123A CA 1325171 C CA1325171 C CA 1325171C
Authority
CA
Canada
Prior art keywords
absorption spectrum
sample
sugar
determined
under measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 583123
Other languages
French (fr)
Inventor
Katsue Koashi
Hiroshi Yokota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kurashiki Spinning Co Ltd
Original Assignee
Kurashiki Spinning Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurashiki Spinning Co Ltd filed Critical Kurashiki Spinning Co Ltd
Application granted granted Critical
Publication of CA1325171C publication Critical patent/CA1325171C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/49Scattering, i.e. diffuse reflection within a body or fluid
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N2021/178Methods for obtaining spatial resolution of the property being measured
    • G01N2021/1782In-depth resolution
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3144Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths for oxymetry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3148Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using three or more wavelengths
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N2021/4704Angular selective
    • G01N2021/4709Backscatter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/065Integrating spheres
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/066Modifiable path; multiple paths in one sample
    • G01N2201/0662Comparing measurements on two or more paths in one sample
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/069Supply of sources
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S250/00Radiant energy
    • Y10S250/91Food sample analysis using invisible radiant energy source

Abstract

ABSTRACT
This disclosure relates to a method for measuring the concentrations of sugars in liquids by the use of near infrared light as well as an apparatus for practicing said method. The method comprises a step wherein the absorption spectrum of the sugar under investigation existing at a first depth relatively close to the surface in a sample is computed by using relatively weak power of near infrared light, a step wherein the absorption spectrum of the sugar under investigation existing at a relatively deep second depth in the sample is computed by using relatively strong power of infrared light, and a step wherein the concentration of the sugar under investigation in the sample is determined by computing the absorption spectrum of the sugar at a different depth between said first and second depths on the basis of the results of measurement in said first and second steps.
The wavelengths used for said absorption spectrum are selected from anyone of wavelength bands of 950-1,150 nm, 1,150-1,300 nm, and 1,300-1,450 nm. Since, according to this method, wavelengths which are shorter and closer to the visible region than in the prior art are used, the method enables the measuring light beams to penetrate deeper in living tissue and makes it possible to measure the concentrations of sugars existing in a deeper region non-invasively.

Description

SDectroscopic Method and Apparatus for Measurina Suqar Concentrations The present invention relates to a spectroscopic method for measuring the concentrations of sugars, e.g. glucose, saccharose, fructose and the like and, more pàrticularly, to a method and apparatus for measuring sugar concentrations in foods, fruits and other agricultural products, and the like and in body fluids of man, animals, and other creatures by a non-invasive or non-destructive and easily repeatable technique, that is, without taking the sugar medium as sample for measurement out of the object of examination.
A non-invasive and easily repeatable measuring method as mentioned above is especially useful in that the method dispenses with the step of taking a sample, for example, a body fluid sample, out of the object of examination in the measurement procedure. In this method, however, it is unsatisfactory that the regions amenable to the measurement should be limited to the outermost layer of the object of examination. For example, in a fruit as an object of such ~ 2~ examination, the pericarp which constitutes the outermost : layer is different from the sarcocarp in the interior of the fruit with respect to the structure of the tissue, and the ` 132517~

composition, the related distribution, and the like of the chemical component. The determination of the sugar concentration in the sarcocarp necessitates relevant measurement at deeper positions than the outermost layer.
In U.S. Patent No. 4,655,225 issued April 17, 1987 to Kurabo Industries Ltd. there is described a prior art technique whereby sugars in human serum, especially glucose therein, can be quantitatively determined non-invasively.
This technique, known as "incident angle modulation method", is a spectroscopic method wherein, in principle, a sample is irradiated with light beams from the outside and the light beams diffused and reflected from within the sample are spectroscopically analyzed. In this method the angle of incidence which the light waves make with a sample is changed. When this angle is small, the light beams penetrate deep underneath the outermost layer, and when the angle is large, the depth to which the light beam penetrates decreases. Therefore, by changing the depth to which a light beam penetrates underneath the outermost layer so as to find the respective spectral signals from the different depths, information from a deeper point, that is, the sugar concentration, can be discretely determined on the basis of the differential signal therebetween.
However, the above-mentioned prior art technique when practiced raises a problem in that the mechanism for - modulating the angle of incidence is complicated on the one hand and the change in the incidence angle of light beam impairs the reproducibility under the influence of a resultant change in the reflection characteristic at the surface of the outer layer.
In the prior art method the light beams used for measurement are of wavelengths in the near infrared region, which are 2,270 ' 15 nm, 2,100 + 15 nm, 1,765 l 15 mn, and 1,575 ~ 15 nm, and the reference wavelengths used are in the range of 1,000 to 2,700 nm. In order to enhance the accuracy of the measurement, however, shorter wavelengths in the near infrared region should be used for the measurement.
The reason is that the liquid in a living body, especially ; in a fruit, agricultural product, or the li~e, consists of water in such a large proportion that the optical penetration depth of light beams to water, which assumes a larger degree on the side of shorter wavelengths, is of importance in the practice.
Wavelengths in the intermediate infrared range, especially those in the range of 7,500 to 15,000 nm called fingerprint region~, are effective in spectral analyses and have long since been used for identification and determination of organic compounds. Since, however, the water existing as a background exhibits such a high rate of absorption for said wavelength region that it is generally : .
considered impractical to determine a specific component . ^ .
-- combined with water by the fingerprint region. Although light beams in the visible region have good optical penetrabi~ity in the water, there exists no spectrum of ' 132517~

characteristic absorption bands for sugar in the visible light region.

~, Accordingly, an essential object of the present invention is to provide a spectroscopic measuring method, according to which the measuring apparatus can be made simpler than in the prior art and by using light beamsof shorter wavelengths in the near infrared region the accuracy of the measurement can be enhanced.
Another object of the present invention is to provide an apparatus which is adapted to the practice of the above-mentioned method of this invention.
In accomplishing the above-mentioned objects there - is provided, according to the present invention, a spectroscopic method for measuring the concentrations of sugars ih samples, which comprises a first step wherein the light intensity of a light source in an interferometer is set at a first prescribed value and the outcoming light beam from said interferometer irradiate a sample placed in an integrating sphere, a second step wherein the diffusely reflected light from said sample collected by an integrating -~ sphere is detected by a photo detector, a third step wherein the absorption spectrum of the sugar under measurement at a - first depth in said sample is determined by processing the ",t,' electrical signal from said photo detector by computer, a fourth step wherein the light intensity of the light source in said interferometer is set at a second prescribed value and the absorption spectrum of the sugar under measurement at a second depth in said sample is determined in the same manner as in said first, second and third steps, and a fifth step wherein the absorption spectrum of the sugar under measurement at a deeper region between said first and second depths in the sample is determined on the basis of the difference between the respective absorption spectrum - determined in said third and fourth steps so that the - concentration of the sugar under measurement in the deeper : 10 region in said sample can be determined on the basis of said absorption spectrum at the deeper region between said first and second depths, the wavelengths used for said absorption spectrum being selected from a wavelength band of from 950 to 1,150 nm, from 1,150 to 1,300 nm, or from 1,300 lS to 1,450 nm.
Since, according to the above-mentioned measuring method, the wavelengths selected for the absorption spec*rum are shorter and closer to the visible region than in the prior art methods, the light beam can penetrate deeper into the living tissue, and therefore, the region in the body tissue amenable to the meas~rement is widened beyond that in the prior art. Where the method of the present invention is used to determine the concentrations of sugars in the -- bloodstream in a human body, the selection of wavelengths from the wavelength bands specified above for the light beam enables them to reach the corium where capillaries are spread or to a point sufficiently close to the corium so I ~25171 that the measurement can be carried out non-invasively, that is, without taking a blood sample.
Another advantage of this method is that the selection of wavelengths as specified above, that is, the use of shorter wavelengths which are closer to the visible region, for the light-throughput~ is increased so that the efficiency of the apparatus can be improved and the accuracy ~- of the measurement can be enhanced.

A further advantage of this method is that, since the technique of d~ging the light intensity of the light source is introduced so as to eliminate the bac~ground noise at the epidermal layer of the sample in measuring the concentratio~s of sugar at a depth beneath it as desired, the practice dispenses with complicated apparatus, e.g.
a light beam incident angle modulator which was required in the prior art.
In accordance with the present invention, there is also provided a spectrophotometric apparatus for measuring the concentrations of sugar in samples, which comprises an interferometer wherein superposed light beams are emitted, a -controller for adjusting the light intensity of the light source which is placed in said interferometer, an integrating sphere to collect diffusely reflected light from a sample placed at said integrating sphere, a phcto detector - 25 for detecting said collected light and converting it into an electric signal, a processing means for processing the electric signal from said photo detector so as to compute 132517~

the absorption spectrum of the sugar in said sample to be determined and for determining the concentration of the sugar under measurement on the basis of said absorption spectrum, and a means for selecting wavelengths for said absorption spectrum from a wavelength band of from 950 to 1,150 nm, from 1,150 to 1,300 nm, or from 1,300 to 1,450 nm.
The processing means includes a means whereby, on the basis ` of the difference between the absorption spectrum of the sugar under measurement at a first depth in said sample which is computed for the light intensity of the light source in said interferometer set at a first.prescribed value and the absorption spectrum of said sugar at a second depth which is computed for the light intensity of said ;: source set at a second prescribed value, the absorption spectrum of the sugar under measurement at a deeper region between said first and second depths in said sample is computed and includes furthermore a means whereby, on the basis of said absorption spectrum at the deeper region between said first and second depths, the concentration of the sugar under measurement in the deeper region in the sample is computed.

These and other objects and features of the ~ - present invention will become apparent from the following .:~ description taken in conjunction with the preferred embodiment thereof with reference to the accompanying drawings, in which:

.

- t325171 Fig. 1 schematically illustrates an apparatus used in the practice of the measuring method of the present invention;
Fig. 2 shows the extinction coefficients of water in the near infrared region;
Fig. 3 shows an absorbance spectrum of purified water, an aqueous solution of glucose, and an aqueous solution of saccharose;
Fig. 4 shows differential spectrum between an - 10 aqueous solution of glucose and pure water;
Fig. 5 shows the differential absorbance with respect to differential spectrum between an aqueous solution of saccharose and pure water;
Fig. 6 shows differential absorbance between pseudo-pure glucose spectrum and pseudo-pure saccharose ` spectrum;
Fig. 7 shows the differential absorbance with ~ respect to the differential spectrum between pseudo-pure -` glucose spectrum and pseudo-pure saccharose spectrum;
Pig. 8 shows the concentrations of glucose determined according to the invention, in relation to the actual measured concentrations, in the test using a~ueous mixtures of glucose and saccharose wherein specific selected -- wavelengths were applied according to a model formula for determining glucose concentrations as described in the example that follows;

.

132517~
g Fig. 9 shows the concentrations of saccharose determined according to the invention, in relation to the actual measured concentrations, in the test using aqueouS
mixtures of glucose and saccharose wherein a model formula for determining saccharose concentrations was used as described in the example that follows; and Figs.10 and 11 are the same representations as Figs. 8 and 9 respectively, except that certain selected optimum wavelengths other than those specified in this invention were used.

The present invention will now be described in ; detail with reference to the accompanying drawings.
Referring to Fig. 1, there is illustrated schematically an apparatus used in the practice of a measuring method embodying the present invention, which is as follows.
The illustration shows a Michelson type interferometer denoted by MI, which comprises a light source 2, a collLmator 7a, i.e. a spherical reflecting mirror, which receives the light from said source 2 and reflects the parallel light beams, a beam splitter 4 that divides the - collimated light beam into two beams R1 and R2 which makes a right angle to each other, one beam directed onto a fixed mirror 3 and the other onto a movable mirror 5. The beams reflected by said fixed mirror 3 and movable mirror 5 are recombined at said beam splitter 4. A movable mirror driving device 6 is arranged so as to move said movable mirror 5 to and fro. Here constructive and destructive interference occurs, depending on the position of the 5 moving mirror S relative to the fixed mirror 3. The light intensity of the light source 2 can be adjusted by a light source intensity controller 1.
The outcoming light beam emitted from the Michelson type interferometer MT passes through a band-pass filter 13 which permits passage of the light beam of predetermined wavelength band. The light beams of a selected wavelength band are directed onto a spherical mirror 8 and reflected thereby into an integrating sphere 9 through the inlet provided therein so as to be focused onto a sample lS placed at a window provided in the integrating - sphere. The light beam penetrates the sample and is then diffusely reflected by the tissue underneath the epidermis and rise to the surface. The reflected light beam from the sample is collected by the integrating sphere and led to a 20 detector lO, which is a photoelectric converter, placed at another window provided in the inteqrating sphere. The electrical signal produced by the detector 10 is amplified by an amplifier 11 and converted by an A/~ converter into a -- digital signal, which is inputted to a computer 12. The signal, seen by the detector as a movable mirror scanning to and fro, is the interferogram.

A detailed explanation will now follow with respect to the wavelength region for the measurements which are selected by the band-pass filter 13.
As touched upon already, in the objects of measurement in the practice of the present invention, which are foods, fruits and other agricultural products, man, animals, and other creatures, the liquid in a living body subjected to the measurement consists of water in such a high proportion that it is essential to consider the absorption of the light beam in water in the study of the application of the present invention.
In Fig. 2 are shown extinction coefficients of water in the near infrared region. The extinction coefficients are shown along the ordinate axis in relation to wavelengths taken on the abscissas axis. As is clearly seen, the absorption of pure water is dependent upon the wavelength and peaks around 1.93 ~m, 1.43 ~m, 1.15 ~m, and 0.96 ~m. And the depth of optical penetration to water is greater where the wavelength is shorter. The absorbance of water at a wavelength of 1.93 ~m differs from that at 0.96 ~m by about three to four orders of magnitude.
Therefore, if a wavelength band capable of determing the chemical component under examination, that is the - sugar, exists in the near infrared region closer to the visible region than the bands for measurement in the prior art, the use of the band enables the light beam to penetrate deeper into a water-containing living tissue and reach a point so deep as to show the chemical component at the value representative of the concentration at the region under investigation. It constitutes another advantage that the use of a wavelength band close to the visible region enhances the light-throughput and, therefore, results in improvement in efficiency of the measuring apparatus.
The present inventors, therefore, examined glucose and saccharose with respect to the feasibility of quantitatively determining each of them individually using wavelengths in the near infrared region, each of the two kinds of sugars closely resembling the other in molecular structure and their test as samples of sugars being of practical value. As a result, it was discovered that, although near infrared spectra of glucose resemble those of saccharose so closely that spectra of their mixture overlap and interfere, there existed bands of shorter wavelengths than in the prior art, with significant differences between the bands. The band-pass filter 13 is designed to pass only the light beam in these specific wavelength bands.
A detailed description will follow with respect to light beam or spectrum in these significant bands.
When samples were aqueous solutions, as shown in Fig. 3, it was difficult to visually distinguish a significant difference in spectra between pure water and an aqueous solution of saccharose or an aqueous solution of glucose. The inventors then examined the differential : ' . ' .
' spectrum between an aqueous solution of glucose and pure water (see Fig. 4) and that between an aqueous solution of saccharose and pure water (see Fig. 5). A differential ; spectrum herein means what remains after subtracting from a spectrum of an aqueous glucose or one of an aqueous saccharose the spectrum of pure water equivalent in quantity to the aqueous constituent of the aqueous glucose or the aqueous saccharose (this differential spectrum will hereinafter be referred to as a spectrum of pseudo-pure glucose or a spectrum of pseudo-pure saccharose). In Figs.
4 and 5 the number assigned to each curve refers to the concentration of glucose or saccharose as follows:
No. 1: 2.0 Mol/~
No. 2: 1.0 Mol/Q
No. 3: 0.5 Mol/~
No. 4: 0.25 Mol/Q
No. 5: 0.125 Mol/Q
Then, to find the differences between the respective spectrum of glucose and saccharose, the spectrum of pseudo-pure glucose was compared with that of pseudo-pure saccharose, as shown in Fig. 6. The resultant differential spectrum (z pseudo-pure glucose spectrum --~ pseudo-pure saccharose spectrum) is shown in Fig. 7. As -- mentioned already, glucose and saccharose closely resemble each other in molecular structure and this fact is reflected in their spectr a as shown in Fig. 6. Despite this similarity in molecular structure, however, significant ;

1 325 1 7 ~

difference can be observed in the wavelength bands of from 1,150 to 1,300 nm and from 950 to 1,150 nm.
- In a spectroscopic analysis of a three-component mixture consisting of glucose, saccharose and pure water, can be determined by introducinq a mathematical formula using individually three specific wavelenqths in said 1,150 to 1,300 nm band with significant differences observable therein, which are 1,230 nm at which the absorbance of glucose is conspicuous and relatively predominant, 1,205 nm at which the absorbance of saccharose is conspicuous and relatively predominant, and a base wavelength of 1,285 nm -- having no relevance to the concentrations of glucose and saccharose. By applying this method unknown samples were determined, Figs. 8 and 9 showing the results. Fig. 8 relates to an aqueous solution mixture of glucose and saccharose and shows the concentrations determined by using a model formula for detenmining glucose concentrations,said determined concentrations shown along the ordinate axis in relation to the actual measured concentrations (known concentrations) taken on the abscissas axis.
~ he spectroscopic determination of the concentrations of components in a chemical system is based upon the Beer-Lambert law which states that the absorbance A
~- is proportional to the concentration C (A = KC ~K is a constant)). Even if it is assumed that the Beer-Lambert law can be expanded and applied to multi-component system, it is - impossible to form a model formula or compute therewith :' 1 325 1 ~ I

unless all possible sets of components in the mixtures are specified. It is generally impracticable to prepare pure standard samples by specifying all possible sets of components especially in complex mixtures, e.g. a living S body.
On the other hand, the application of the inverse Beer-Lambert law ~C = PA (C is a constant)), wherein the concentration C is regarded as a function of the absorbance A, enables a model to be formed and used in the computation in relation to specific components, that is, without the need to specify all possible sets of components in a system. In other words~ for example, a model formula can be formed for practical computation with respect to the concentration of glucose in a multicomponent system.
A model formula will be explained hereunder using a linear combination comprising, for example, absorbances at three different wavelengths.
C = ~PiA(Ai)+Po = PlA(Al)+P2A(A2)+P3A(A3)+Po .............. (1) where A(Al), A(A2), and A(A3) are the absorbances at selected wavelengths of Al, A2, and 13;
Pl, P2, and P3 are proportional constants for the absorbances A~Ai);
- Po is an intercept term of the model.
The absorbance A~Ai) at the selected optimum specific wavelength Ai is divided into a component absorbance Ag~Ai) depending on the concentration of qlucose -and a component absorbance Ab(Ai) depending on the components other than glucose in the system.
A(Ai) = Ag(Ai)+Ab(Ai) .(2) Ab(Ai) includes, besides the contribution from the sugar 5 components other than glucose, the contribution from the background.
Then, by applying the equation (2) the equation (1) can be - developed as follows:
C = PlA(Al)+P2A(12)+P3A(A3)+Po = Pl{Ag(Al)+Ab(Al)}+P2{Ag(A2)+Ab(A2)}
+P3{Ag(A3)+Ab(A3)}+Pgo+Pbo = {PlAg(Al)+P2Ag(A2)+P3Ag(A3)+Pgo}
+{PlAb(Al)+P2Ab~A2)+P3Ab~A3)+Pbo} ....... (3) Hence, Cg = {PlAg(Al)+P2Ag(12)+P3Ag(A3)+Pgo} ....... (4) ; and Cb = {PlAb(Al)+P2Ab(A2)+P3Ab(A3)+Pbo} ....... (5) where Cg is a term depending on the glucose component and represents the true concentration of glucose; Cb represents the contribution from the components other than glucose and that from the background. Then, most optimum wavelengths Al, A2, and A3, optimum coefficients Pl, P2, and P3, and Po are determined by multiregression in such a way as to - satisfy ; 25 Cb = PlAb(Al)+P2Ab(A2)+P3Ab(A3~+Pbo ~ 0 ..... (6) By thus cancelling the contribution from the components other than glucose and that from the background, Cg ' :~i . -. . . ,- .

representing the true concentration of glucose under investigation becomes obtainable in the model formula.
Since the equation (4) becomes almost equal to the equation (1), the concentration of glucose can be obtained by measuring the absorbances A(Al), A(~2), and A~A3) at selected optimum wavelengths of Al, A2, and A3. Since the concentration of glucose is under investigation, the equation (1) is remodelled into Cg = PglA(Al)+Pg2A(A2)+Pg3A(A3)+PgO ----(7) The concentrations of the components other than glucose can be obtained in a manner similar to the above procedure.
A linear combination of absorbances at three wavelengths has been dealt with in explaining the model formula, but, without restricting the practice of this invention to this particular type of formulae, a model formula using absorbances at four wavelengths or more, doublet, or cross-product absorbance terms can be formed so as to be adapted to the accuracy required or particular cases of application.
An explanation will be gi~en next with respect to the results of analysis obtained by using the equation (7) as a model formula.
Three selected specific optimum wavelengths in the band of 1,150-1,300 nm are 11 = 1,205 nm, A2 = 1,230 nm, and ~3 = 1,28S nm. In Fig. 8, wherein the concentrations 25 determined according to the invention are shown in relation to the actual measured concentrations, the straight line is ~ 4:
,:
', - l& -the 45 degree on which all the points should lie in the absence of error. The marks ~Ou plotted therein, each representing the results obtained relating to a certain number of samples, lie along the straight line and shows that glucose can be individually determined by the use of said selected specific optimum wavelengths.
In a manner similar to the procedure for glucose mentioned above, saccharose can also be individually determined by using the three specific optimum wavelengths 10 ~1,205 nm, 1,230 nm, and 1,285 nm). Fig. 9 shows, with respect to aqueous mixtures of glucose and saccharose, the concentrations determined by using a model formula for determining concentrations of saccharose along the axis of ordinate in relation to the actual measured concentrations (previously known concentrations) taken on the abscissas axis. The results obtained with respect to each sample lie around the straight line on which all the points should lie in the absence of error.
; Similarly, glucose, saccharose and pure water in a three component system can each be individually determined by the use of three optimum wavelengths 1950 nm, 980 nm, and 1,107 nm) in the band of from 950 to 1,150 nm where significant differences are shown.
- Also in the band of from 1,300 to 1,450 nm ~;
significant differences are seen in spectrum between glucose and saccharose (Fig. 7 shows this phenomenon only in part).
herefore, by using three optimum wavelengths ~1,349 nm, 132517~

1,385 nm, and 1,400 nm) in this band each of said components can be separated in spectrum. In a manner similar to the above-mentioned example, analytical graphs were obtained mathematically with respect to unknown samples. The results in Fig. 10 (concentrations of glucose) and Fig. 11 (concentrations of saccharose) show better linearity in the relationship between the determined concentrations and the actual measured concentrations.
The wavelengths for the light beam used in the measuring apparatus in Fig. 1 are selected from any of the - three wavelength bands, i.e., 950-1,150 nm, 1,150-1,300 nm, and 1,300-1,450 nm, as mentioned above.
Referring to Fig. 1, a detailed description will now follow with respect to the method of measurement of the concentrations of sugars in the tissue, particularly those of glucose as an example, at the depth b of the sample 15.
The first step begins with adjusting the light from the light source 2 to a prescribed intensity by means of the light source intensity controller 1 so as to examine the spectrum of the tissue at the outermost layer a of the sample. In other words, the light beams irradiating the sample 15 is so adjusted as to enter only the outermost layer a and be reflected back toward the outside. The spectrum pertaining to the outermost layer a of the sample 15 is then measured. The band-pass filter 13 then permits passage of the light beam of the necessary wavelength band, for example, in the range of 1,150-1,300 nm.

~'' ' In the second step, the intensity of the light from the source is increased by the light source intensity controller 1 so as to enable the light beam from the interferometer MI sphere 9 to penetrate the sample lS deeper S to a depth b. In this way the spectrum of the sample 15 pertaining to both the outermost layer a and the deeper layer b are computed. For this deeper layer b, too, the computer 12 executes a program similar to that for the outermost layer a for the measurement.
In the third step, the computer 12 first computes the differential spectrum between the two spectra obtained at the first step and the second step, secondly selects a number of wavelengths necessary for determining the concentration of the component under investigation, that is, 15 the glucose, from said wavelength band of 1,150-1,300 nm, ; for example, three wavelengths of 1,205 nm, 1,230 nm, and 1,285 nm therefromj and thirdly determines the concentration cf glucose by introducing these selected wavelengths into a ~ prescribed mathematical equation as hereinbefore described.
; 20 By following the above-mentioned spectrum procedure the background from the outermost layer a where glucose is not at all present or not contained to any significant degree can be eliminated and the concentration -- of glucose in the tissue at a deeper point b can be determined.
Although the present invention has been fully described by way of example with reference to the 1 3~5 1 7 1 accompanying drawings, it is to be noted, here, that various changes and modifications will be apparent to those skilled in the art. Therefore, unless otherwise such changes and modifications depart from the scope of the present 5 invention, they should be construed as included therein.

`:

.
,

Claims (5)

1. A spectroscopic method for measuring concentrations of sugars in samples, which comprises a first step wherein light intensity of a light source in an interferometer is set at a first prescribed value and outcoming light beams from said interferometer are emitted into an integrating sphere to irradiate a sample placed at a sample aperture of said integrating sphere, a second step wherein diffusely reflected light beams from said sample are detected by a photo detector, a third step wherein absorption spectrum of the sugar under measurement at a first depth in said sample is determined by processing electrical signals from said photo detector by a computer, a fourth step wherein the light intensity of the light source in said interferometer is set at a second prescribed value and absorption spectrum of the sugar under measurement at a second depth in said sample is determined in the same manner as in said first, second and third steps, and a fifth step wherein absorption spectrum of the sugar under measurement at a deeper region between said first and second depths in the sample is determined on the basis of the difference between the respective absorption spectrum determined in said third and fourth steps so that the concentration of the sugar under measurement in said deeper region in said sample can be determined on the basis of said absorption spectrum at said deeper region, the wavelengths used for said absorption spectrum being selected from a wavelength band of from 950 to 1,150 nm, from 1,150 to 1,300 nm, or from 1,300 to 1,450 nm.
2. A spectroscopic method as claimed in Claim 1, wherein said wavelengths used for said absorption spectrum comprise three or more in number selected from any one of said wavelength bands.
3. A spectroscopic method as claimed in Claim 1, wherein the sugar to be determined is selected from the group consisting of glucose, saccharose, and fructose.
4. A spectroscopic method as claimed in Claim 1, wherein the sugar to be determined is a sugar in human blood.
5. A spectrophotometric apparatus for measuring concentrations of sugars in samples, which comprises an interferometer for emitting superposed light beams, a controller for adjusting light intensity of a light source which is placed in said interferometer, an integrating sphere for collecting diffusely reflected light beams from a sample placed at said integrating sphere, a photo detector for detecting said collected light and converting it into an electric signal, a processing means for processing electric signal from said photo detector so as to compute absorption spectrum of the sugar in said sample to be determined and for determining the concentration of the sugar under measurement on the basis of said absorption spectrum, and a means for selecting optimum wavelengths used for said absorption spectrum from a wavelength band of from 950 to 1,150 nm, from 1,150 to 1,300 nm, or from 1,300 to 1,450 nm, said processing means including a means whereby, on the basis of the difference between the absorption spectrum of the sugar under measurement at a first depth in said sample which is computed for light intensity of said light source in said interferometer set at a first prescribed value and absorption spectrum of said sugar at a second depth which is computed for light intensity of said source set at a second prescribed value, the absorption spectrum of the sugar under measurement at a deeper region between said first and second depths in said sample is computed and including furthermore a means whereby, on the basis of said absorption spectrum at said deeper region, the concentration of the sugar under measurement in said deeper-region in the sample is computed.
CA 583123 1987-11-17 1988-11-15 Spectroscopic method and apparatus for measuring sugar concentrations Expired - Fee Related CA1325171C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29082187A JPH0827235B2 (en) 1987-11-17 1987-11-17 Spectroscopic method for measuring sugar concentration
JP290821/1987 1987-11-17

Publications (1)

Publication Number Publication Date
CA1325171C true CA1325171C (en) 1993-12-14

Family

ID=17760917

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 583123 Expired - Fee Related CA1325171C (en) 1987-11-17 1988-11-15 Spectroscopic method and apparatus for measuring sugar concentrations

Country Status (6)

Country Link
US (1) US4883953A (en)
EP (1) EP0317121B1 (en)
JP (1) JPH0827235B2 (en)
AT (1) ATE101270T1 (en)
CA (1) CA1325171C (en)
DE (1) DE3887641T2 (en)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028787A (en) * 1989-01-19 1991-07-02 Futrex, Inc. Non-invasive measurement of blood glucose
US5086229A (en) * 1989-01-19 1992-02-04 Futrex, Inc. Non-invasive measurement of blood glucose
US5077476A (en) * 1990-06-27 1991-12-31 Futrex, Inc. Instrument for non-invasive measurement of blood glucose
US5068536A (en) * 1989-01-19 1991-11-26 Futrex, Inc. Method for providing custom calibration for near infrared instruments for measurement of blood glucose
US5218207A (en) * 1989-01-19 1993-06-08 Futrex, Inc. Using led harmonic wavelengths for near-infrared quantitative
US4975581A (en) * 1989-06-21 1990-12-04 University Of New Mexico Method of and apparatus for determining the similarity of a biological analyte from a model constructed from known biological fluids
DE69023859T2 (en) * 1989-09-20 1996-07-25 Kurashiki Boseki Kk Method and device for the quantitative determination of chemicals for the treatment of semiconductors.
CA2028261C (en) * 1989-10-28 1995-01-17 Won Suck Yang Non-invasive method and apparatus for measuring blood glucose concentration
JP2964518B2 (en) * 1990-01-30 1999-10-18 日本電気株式会社 Voice control method
US5222495A (en) * 1990-02-02 1993-06-29 Angiomedics Ii, Inc. Non-invasive blood analysis by near infrared absorption measurements using two closely spaced wavelengths
IE77034B1 (en) * 1990-06-27 1997-11-19 Futrex Inc Non-invasive masurement of blood glucose
JP2517858B2 (en) * 1991-10-04 1996-07-24 農林水産省食品総合研究所長 Nondestructive measurement method of fruit sugar content by near infrared transmission spectrum
US5818048A (en) * 1992-07-15 1998-10-06 Optix Lp Rapid non-invasive optical analysis using broad bandpass spectral processing
US5424545A (en) * 1992-07-15 1995-06-13 Myron J. Block Non-invasive non-spectrophotometric infrared measurement of blood analyte concentrations
US6222189B1 (en) 1992-07-15 2001-04-24 Optix, Lp Methods of enhancing optical signals by mechanical manipulation in non-invasive testing
IL107396A (en) * 1992-11-09 1997-02-18 Boehringer Mannheim Gmbh Method and apparatus for analytical determination of glucose in a biological matrix
DE4314835A1 (en) * 1993-05-05 1994-11-10 Boehringer Mannheim Gmbh Method and device for analysing glucose in a biological matrix
US5379764A (en) * 1992-12-09 1995-01-10 Diasense, Inc. Non-invasive determination of analyte concentration in body of mammals
US5533509A (en) * 1993-08-12 1996-07-09 Kurashiki Boseki Kabushiki Kaisha Method and apparatus for non-invasive measurement of blood sugar level
DE4328532A1 (en) * 1993-08-25 1995-03-02 Pfeuffer Gmbh Mes Und Pruefger Device for quantitative determination of the materials contained in agricultural products
JPH07250826A (en) * 1994-03-14 1995-10-03 Sony Corp Blood sugar value measuring apparatus
TW275570B (en) * 1994-05-05 1996-05-11 Boehringer Mannheim Gmbh
US5836317A (en) * 1994-05-20 1998-11-17 Kunst; Hermann Transcutaneous non-bloody determination of the concentration of substances in the blood
US5743262A (en) * 1995-06-07 1998-04-28 Masimo Corporation Blood glucose monitoring system
US6240306B1 (en) 1995-08-09 2001-05-29 Rio Grande Medical Technologies, Inc. Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration
US6040578A (en) * 1996-02-02 2000-03-21 Instrumentation Metrics, Inc. Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopy
US5747806A (en) * 1996-02-02 1998-05-05 Instrumentation Metrics, Inc Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy
DE19619513C2 (en) * 1996-05-14 2001-03-22 Stoeckert Instr Gmbh Device for measuring physiological parameters of blood in an extracorporeal circuit
US5666956A (en) * 1996-05-20 1997-09-16 Buchert; Janusz Michal Instrument and method for non-invasive monitoring of human tissue analyte by measuring the body's infrared radiation
US5818045A (en) * 1996-07-19 1998-10-06 Mark; Howard L. Spectroscopic system for quantifying constituents in natural products
CA2231305C (en) * 1997-03-11 2007-03-20 Merrit Nyles Jacobs Improved analyzer throughput featuring through-the-tip analysis
US6628809B1 (en) 1999-10-08 2003-09-30 Lumidigm, Inc. Apparatus and method for identification of individuals by near-infrared spectrum
US7890158B2 (en) 2001-06-05 2011-02-15 Lumidigm, Inc. Apparatus and method of biometric determination using specialized optical spectroscopy systems
FR2775345B1 (en) * 1998-02-26 2000-05-19 Cemagref PROCESS AND PLANT FOR MEASURING THE CONTENT, IN PARTICULAR OF SUGAR, OF FRUITS AND VEGETABLES
US6816605B2 (en) 1999-10-08 2004-11-09 Lumidigm, Inc. Methods and systems for biometric identification of individuals using linear optical spectroscopy
US6512577B1 (en) 2000-03-13 2003-01-28 Richard M. Ozanich Apparatus and method for measuring and correlating characteristics of fruit with visible/near infra-red spectrum
JP2001272272A (en) * 2000-03-24 2001-10-05 Ushikata Shokai:Kk Monitor for light
US6477392B1 (en) * 2000-07-14 2002-11-05 Futrex Inc. Calibration of near infrared quantitative measurement device using optical measurement cross-products
US6741876B1 (en) 2000-08-31 2004-05-25 Cme Telemetrix Inc. Method for determination of analytes using NIR, adjacent visible spectrum and discrete NIR wavelenths
US6862091B2 (en) 2001-04-11 2005-03-01 Inlight Solutions, Inc. Illumination device and method for spectroscopic analysis
US6574490B2 (en) 2001-04-11 2003-06-03 Rio Grande Medical Technologies, Inc. System for non-invasive measurement of glucose in humans
US20070276199A1 (en) * 2002-04-04 2007-11-29 Ediger Marwood N Determination of a Measure of a Glycation End-Product or Disease State Using Tissue Fluorescence
US7139598B2 (en) * 2002-04-04 2006-11-21 Veralight, Inc. Determination of a measure of a glycation end-product or disease state using tissue fluorescence
US6865408B1 (en) 2001-04-11 2005-03-08 Inlight Solutions, Inc. System for non-invasive measurement of glucose in humans
US7126682B2 (en) 2001-04-11 2006-10-24 Rio Grande Medical Technologies, Inc. Encoded variable filter spectrometer
US6983176B2 (en) 2001-04-11 2006-01-03 Rio Grande Medical Technologies, Inc. Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy
US7043288B2 (en) 2002-04-04 2006-05-09 Inlight Solutions, Inc. Apparatus and method for spectroscopic analysis of tissue to detect diabetes in an individual
US7027848B2 (en) 2002-04-04 2006-04-11 Inlight Solutions, Inc. Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte
US6654125B2 (en) 2002-04-04 2003-11-25 Inlight Solutions, Inc Method and apparatus for optical spectroscopy incorporating a vertical cavity surface emitting laser (VCSEL) as an interferometer reference
US8131332B2 (en) * 2002-04-04 2012-03-06 Veralight, Inc. Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites
US8140147B2 (en) * 2002-04-04 2012-03-20 Veralight, Inc. Determination of a measure of a glycation end-product or disease state using a flexible probe to determine tissue fluorescence of various sites
AUPS332802A0 (en) * 2002-07-03 2002-07-25 Iwrx Pty Ltd Sucrose monitor
US7620212B1 (en) 2002-08-13 2009-11-17 Lumidigm, Inc. Electro-optical sensor
CN100483106C (en) * 2002-09-29 2009-04-29 天津市先石光学技术有限公司 Optical method for detecting discerptible medium skin layer and deep layer information
WO2004044558A2 (en) * 2002-11-14 2004-05-27 Foss Analytical A/S A method and apparatus for determining a property of a sample
JP3694291B2 (en) * 2002-11-21 2005-09-14 倉敷紡績株式会社 Blood glucose level non-invasive measurement device
US7545963B2 (en) 2003-04-04 2009-06-09 Lumidigm, Inc. Texture-biometrics sensor
US7751594B2 (en) 2003-04-04 2010-07-06 Lumidigm, Inc. White-light spectral biometric sensors
US7668350B2 (en) 2003-04-04 2010-02-23 Lumidigm, Inc. Comparative texture analysis of tissue for biometric spoof detection
US7627151B2 (en) 2003-04-04 2009-12-01 Lumidigm, Inc. Systems and methods for improved biometric feature definition
AU2004227886A1 (en) 2003-04-04 2004-10-21 Lumidigm, Inc. Multispectral biometric sensor
US7460696B2 (en) 2004-06-01 2008-12-02 Lumidigm, Inc. Multispectral imaging biometrics
US7539330B2 (en) 2004-06-01 2009-05-26 Lumidigm, Inc. Multispectral liveness determination
US7394919B2 (en) 2004-06-01 2008-07-01 Lumidigm, Inc. Multispectral biometric imaging
US7347365B2 (en) 2003-04-04 2008-03-25 Lumidigm, Inc. Combined total-internal-reflectance and tissue imaging systems and methods
WO2005007215A2 (en) * 2003-07-09 2005-01-27 Glucolight Corporation Method and apparatus for tissue oximetry
US7263213B2 (en) 2003-12-11 2007-08-28 Lumidigm, Inc. Methods and systems for estimation of personal characteristics from biometric measurements
WO2005058154A1 (en) * 2003-12-16 2005-06-30 Medeikon Corporation Method for monitoring of analytes in biological samples using low coherence interferometry
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
AU2005220794A1 (en) * 2004-03-06 2005-09-22 Calisto Medical, Inc. Methods and devices for non-invasively measuring quantitative information of substances in living organisms
US7242480B2 (en) * 2004-05-14 2007-07-10 Medeikon Corporation Low coherence interferometry for detecting and characterizing plaques
US7184148B2 (en) 2004-05-14 2007-02-27 Medeikon Corporation Low coherence interferometry utilizing phase
US7190464B2 (en) * 2004-05-14 2007-03-13 Medeikon Corporation Low coherence interferometry for detecting and characterizing plaques
US7327463B2 (en) 2004-05-14 2008-02-05 Medrikon Corporation Low coherence interferometry utilizing magnitude
US20050254059A1 (en) * 2004-05-14 2005-11-17 Alphonse Gerard A Low coherence interferometric system for optical metrology
US7474408B2 (en) 2004-05-14 2009-01-06 Medeikon Corporation Low coherence interferometry utilizing phase
US8229185B2 (en) 2004-06-01 2012-07-24 Lumidigm, Inc. Hygienic biometric sensors
US20110163163A1 (en) * 2004-06-01 2011-07-07 Lumidigm, Inc. Multispectral barcode imaging
US7508965B2 (en) 2004-06-01 2009-03-24 Lumidigm, Inc. System and method for robust fingerprint acquisition
US7502110B2 (en) * 2004-07-21 2009-03-10 Lighthouse Worldwide Solutions, Inc Design for particle sensor system
US8787630B2 (en) 2004-08-11 2014-07-22 Lumidigm, Inc. Multispectral barcode imaging
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
EP1874178A4 (en) 2005-04-13 2009-12-09 Glucolight Corp Method for data reduction and calibration of an oct-based blood glucose monitor
US7801338B2 (en) * 2005-04-27 2010-09-21 Lumidigm, Inc. Multispectral biometric sensors
US7488930B2 (en) * 2006-06-02 2009-02-10 Medeikon Corporation Multi-channel low coherence interferometer
US8594770B2 (en) * 2006-06-29 2013-11-26 Accuvein, Inc. Multispectral detection and presentation of an object's characteristics
US7995808B2 (en) 2006-07-19 2011-08-09 Lumidigm, Inc. Contactless multispectral biometric capture
US8355545B2 (en) 2007-04-10 2013-01-15 Lumidigm, Inc. Biometric detection using spatial, temporal, and/or spectral techniques
KR101349892B1 (en) 2006-07-19 2014-01-13 루미다임 인크. Multibiometric multispectral imager
US8175346B2 (en) 2006-07-19 2012-05-08 Lumidigm, Inc. Whole-hand multispectral biometric imaging
US7804984B2 (en) 2006-07-31 2010-09-28 Lumidigm, Inc. Spatial-spectral fingerprint spoof detection
US7801339B2 (en) 2006-07-31 2010-09-21 Lumidigm, Inc. Biometrics with spatiospectral spoof detection
DE102006048849B4 (en) * 2006-10-16 2018-05-09 Carl Zeiss Ag Method and device for measuring the concentration of at least one substance from a group of n substances located in a sample material and influencing the dispersion of the sample material
JP2010522379A (en) 2007-03-21 2010-07-01 ルミダイム インコーポレイテッド Biometric authentication based on locally invariant features
CN101201319B (en) * 2007-11-30 2010-06-02 中国计量学院 Near-infrared spectrometer
WO2009111542A2 (en) 2008-03-04 2009-09-11 Glucolight Corporation Methods and systems for analyte level estimation in optical coherence tomography
JP2009236565A (en) * 2008-03-26 2009-10-15 Jasco Corp Automatic continuous quantifying and analyzing method of plurality of components and automatic continuous quantifying and analyzing apparatus
US20110004080A1 (en) 2008-04-11 2011-01-06 Glucovista, Llc Method for non-invasive analysis of a substance concentration within a body
CN101292875B (en) * 2008-06-06 2010-07-14 天津市先石光学技术有限公司 Method for measuring component concentration with reference wavelength
BR122013021647A2 (en) 2009-08-26 2016-04-05 Lumidigm Inc object locating, object discrimination and background methods, and
US8570149B2 (en) 2010-03-16 2013-10-29 Lumidigm, Inc. Biometric imaging using an optical adaptive interface
JP6323060B2 (en) * 2014-02-25 2018-05-16 セイコーエプソン株式会社 Component analyzer, component analysis method
SG11201705169UA (en) * 2014-12-22 2017-08-30 Edvard Vladimirovich Kryzhanovskii Method for noninvasively determining blood glucose concentration
WO2022009577A1 (en) * 2020-07-06 2022-01-13 Look Tec株式会社 Blood measurement device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281645A (en) * 1977-06-28 1981-08-04 Duke University, Inc. Method and apparatus for monitoring metabolism in body organs
US4463261A (en) * 1981-05-07 1984-07-31 National Research Development Corporation Analysis apparatus
GB8425274D0 (en) * 1984-10-05 1984-11-14 Spandrel Etab Signal responsive to parameter of objects
US4655225A (en) * 1985-04-18 1987-04-07 Kurabo Industries Ltd. Spectrophotometric method and apparatus for the non-invasive
US4755048A (en) * 1986-10-23 1988-07-05 Amoco Corporation Optical analysis of impurity absorptions

Also Published As

Publication number Publication date
US4883953A (en) 1989-11-28
JPH0827235B2 (en) 1996-03-21
EP0317121B1 (en) 1994-02-02
ATE101270T1 (en) 1994-02-15
JPH01131436A (en) 1989-05-24
EP0317121A3 (en) 1990-07-04
DE3887641T2 (en) 1994-05-05
DE3887641D1 (en) 1994-03-17
EP0317121A2 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
CA1325171C (en) Spectroscopic method and apparatus for measuring sugar concentrations
CN100590417C (en) Plant blade physiologic index non-destructive test method
US6061582A (en) Method and apparatus for non-invasive determination of physiological chemicals, particularly glucose
Lammertyn et al. Light penetration properties of NIR radiation in fruit with respect to non-destructive quality assessment
JP2517858B2 (en) Nondestructive measurement method of fruit sugar content by near infrared transmission spectrum
US6040578A (en) Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopy
US5751418A (en) Spectrometry and optical method and apparatus for obtaining a stable spectrum with use of an informationless spectrum contained therein
US5533509A (en) Method and apparatus for non-invasive measurement of blood sugar level
US5757002A (en) Method of and apparatus for measuring lactic acid in organism
Saranwong et al. Improvement of PLS calibration for Brix value and dry matter of mango using information from MLR calibration
KR20170017937A (en) Non-invasive substance analysis
JP3248905B2 (en) Method for analyzing biological substances having a water content
US20030011773A1 (en) Non-invasive measurement of skin bilirubin level
US5089701A (en) Nondestructive measurement of soluble solids in fruits having a rind or skin
Leonardi et al. Quantitative multiwavelength constituent measurements using single-wavelength photon time-of-flight correction
JP3315546B2 (en) Pesticide residue analysis method
JPH04208842A (en) Method and device for measuring sugar content of vegetable and fruit
JP2004317381A (en) Apparatus for nondestructively measuring sugar content of fruits and vegetables
JP2003149145A (en) Non-invasive glucose level measuring device
GB2406638A (en) Interferometric measurement apparatus and method
Liu et al. Application of near-infrared spectroscopy with fiber optics for detecting interior quality in peaches
JPH02290537A (en) Method for estimating eating taste value by near infrared ray
JPH0850093A (en) Spectroscopic measurement of glucose concentration
CA2376747A1 (en) Apparatus for quantitative in vivo optical measurement of a mammalian analyte concentration and use thereof
JP2011506915A (en) Method and measuring instrument for collecting spectroscopic examination signals from biological tissue

Legal Events

Date Code Title Description
MKLA Lapsed